- Blood and marrow stem cell transplant for the treatment of Hodgkin's disease.
- Blood and marrow stem cell transplant for the treatment of Non-Hodgkin's lymphoma.
- Protocol: Y2B8 radioimmunoconjugate therapy combined with BEAM conditioning for autologous stem cell transplantation of patients with CD20 positive Non-Hodgkin's lymphoma.
Therapeutic trials for mantle cell non-Hodgkin Lymphoma. Protocol in North Central Cancer Treatment Group (NCCTG), Rituximab cladribine and temsirolimus for mantle cell NHL.